-
Association of IFNAR1 and IFNAR2 with COVID-19 severity
-
The Lancet Microbe: Yaugel-Novoa M., Bourlet T., Longet S., Botehlo-Nevers E, Paul S. https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00095-2/fulltext
Located in
Teams
/
Paul S - GIMAP
/
Actualités
-
mTOR Activation Underlies Enhanced B Cell Proliferation and Autoimmunity in PrkcdG510S/G510S Mice
-
Moreews M ; Mathieu AL, Pouxvielh K... Marçais A, Walzer T, Belot A
Located in
Teams
/
Walzer T - LYACTS
/
Actualités
-
New publication COVID Nature communication
-
New publication - VIV Team in Nature communication
Located in
Teams
/
Dreux M - VIV
/
News
-
Prior SARS-CoV-2 infection enhances and reshapes spike protein-specific memory induced by vaccination
-
Located in
Teams
/
Walzer T - LYACTS
/
Actualités
-
An inventory of adjuvants used for vaccination in horses: the past, the present and the future.
-
Carnet F, Perrin-Cocon L, Paillot R, Lotteau V, Pronost S, Vidalain PO.
Located in
Teams
/
VIDALAIN PO - VIRIMI
/
News
-
Interferon-dependent and independent mechanisms drive Hepatitis Delta Virus interference on Hepatitis B Virus RNA production
-
Lucifora et al., Journal of Hepatology, 2023 / Team HepVir
Located in
Teams
/
Durantel D - HepVir
/
What's new for us?
-
Farnesoid X receptor alpha ligands inhibit hepatitis delta virus in vitro replication and virion infectivity
-
Legrand, Lucifora et al., Hepatology Communications, 2023 / Team VIRIMI and Team HepVir
Located in
Teams
/
Durantel D - HepVir
/
What's new for us?
-
Last publication form the team
-
Grass, V. et al., Communication Biology 2022, VIV Team.
Located in
Teams
/
Dreux M - VIV
/
News
-
Induction of a strong and long-lasting neutralizing immune response by dPreS1-TLR2 agonist nanovaccine against HBV
-
Lamrayat et al., Antiviral Research, 2023 / Team HepVir
Located in
Teams
/
Durantel D - HepVir
/
What's new for us?
-
A stable hepatitis D virus-producing cell line for host target and drug discovery
-
Bach, Lucifora et al., Antiviral Research, 2023 / Team HepVir
Located in
Teams
/
Durantel D - HepVir
/
What's new for us?
